Long-Term Investor Investigation of Potential Wrongdoing at Biogen Inc Announced
An investigation on behalf of investors in shares of Biogen Inc (NASDAQ:BIIB) concerning potential breaches of fiduciary duties by certain directors and officers of Biogen Inc was announced.
View full press release